(1)
Tha├ži, D.; Armstrong, A.; Gordon, K. B.; Blauvelt, A.; Paul, C.; Boehncke, W.-H.; Wang, M.; Szilagyi, B. .; Hoepken, B.; Lambert, J.; Lebwohl, M. Bimekizumab 3-Year Maintenance of Response in Week 16 Responders With Moderate to Severe Plaque Psoriasis: Results from Five Phase 3/3b Trials. J of Skin 2024, 8, s306.